Global Hemoglobinopathy Testing Services Supply, Demand and Key Producers, 2024-2030

Page: 94

Published Date: 22 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.

The global Hemoglobinopathy Testing Services market size is expected to reach $ 1718 million by 2030, rising at a market growth of 9.1% CAGR during the forecast period (2024-2030).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report studies the global Hemoglobinopathy Testing Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemoglobinopathy Testing Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemoglobinopathy Testing Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hemoglobinopathy Testing Services total market, 2019-2030, (USD Million)
Global Hemoglobinopathy Testing Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Hemoglobinopathy Testing Services total market, key domestic companies, and share, (USD Million)
Global Hemoglobinopathy Testing Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Hemoglobinopathy Testing Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Hemoglobinopathy Testing Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Hemoglobinopathy Testing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company, Celgene Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Hemoglobinopathy Testing Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hemoglobinopathy Testing Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hemoglobinopathy Testing Services Market, Segmentation by Type
    Hydroxyurea
    Glutamine
    Zynteglo
    Luspatercept
    Others

Global Hemoglobinopathy Testing Services Market, Segmentation by Application:
    Sickle Cell Diseases
    Thalassemia
    Other

Companies Profiled:
    Novartis
    AstraZeneca
    Bluebird Bio
    Bristol-Myers Squibb
    Emmaus Medical
    Acceleron Pharma
    HemaQuest Pharmaceuticals
    Eli Lilly and Company
    Celgene Corporation

Key Questions Answered
1. How big is the global Hemoglobinopathy Testing Services market?
2. What is the demand of the global Hemoglobinopathy Testing Services market?
3. What is the year over year growth of the global Hemoglobinopathy Testing Services market?
4. What is the total value of the global Hemoglobinopathy Testing Services market?
5. Who are the Major Players in the global Hemoglobinopathy Testing Services market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hemoglobinopathy Testing Services Introduction
    1.2 World Hemoglobinopathy Testing Services Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Hemoglobinopathy Testing Services Total Market by Region (by Headquarter Location)
        1.3.1 World Hemoglobinopathy Testing Services Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.3 China Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.4 Europe Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.5 Japan Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.6 South Korea Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.7 ASEAN Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
        1.3.8 India Based Company Hemoglobinopathy Testing Services Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hemoglobinopathy Testing Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.2 World Hemoglobinopathy Testing Services Consumption Value by Region
        2.2.1 World Hemoglobinopathy Testing Services Consumption Value by Region (2019-2024)
        2.2.2 World Hemoglobinopathy Testing Services Consumption Value Forecast by Region (2025-2030)
    2.3 United States Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.4 China Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.5 Europe Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.6 Japan Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.7 South Korea Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.8 ASEAN Hemoglobinopathy Testing Services Consumption Value (2019-2030)
    2.9 India Hemoglobinopathy Testing Services Consumption Value (2019-2030)

3 World Hemoglobinopathy Testing Services Companies Competitive Analysis
    3.1 World Hemoglobinopathy Testing Services Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Hemoglobinopathy Testing Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Hemoglobinopathy Testing Services in 2023
        3.2.3 Global Concentration Ratios (CR8) for Hemoglobinopathy Testing Services in 2023
    3.3 Hemoglobinopathy Testing Services Company Evaluation Quadrant
    3.4 Hemoglobinopathy Testing Services Market: Overall Company Footprint Analysis
        3.4.1 Hemoglobinopathy Testing Services Market: Region Footprint
        3.4.2 Hemoglobinopathy Testing Services Market: Company Product Type Footprint
        3.4.3 Hemoglobinopathy Testing Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Hemoglobinopathy Testing Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Hemoglobinopathy Testing Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Hemoglobinopathy Testing Services Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Hemoglobinopathy Testing Services Consumption Value Comparison
        4.2.1 United States VS China: Hemoglobinopathy Testing Services Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hemoglobinopathy Testing Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Hemoglobinopathy Testing Services Companies and Market Share, 2019-2024
        4.3.1 United States Based Hemoglobinopathy Testing Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Hemoglobinopathy Testing Services Revenue, (2019-2024)
    4.4 China Based Companies Hemoglobinopathy Testing Services Revenue and Market Share, 2019-2024
        4.4.1 China Based Hemoglobinopathy Testing Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Hemoglobinopathy Testing Services Revenue, (2019-2024)
    4.5 Rest of World Based Hemoglobinopathy Testing Services Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Hemoglobinopathy Testing Services Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Hemoglobinopathy Testing Services Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Hemoglobinopathy Testing Services Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Hydroxyurea
        5.2.2 Glutamine
        5.2.3 Zynteglo
        5.2.4 Luspatercept
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Hemoglobinopathy Testing Services Market Size by Type (2019-2024)
        5.3.2 World Hemoglobinopathy Testing Services Market Size by Type (2025-2030)
        5.3.3 World Hemoglobinopathy Testing Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Hemoglobinopathy Testing Services Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Sickle Cell Diseases
        6.2.2 Thalassemia
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Hemoglobinopathy Testing Services Market Size by Application (2019-2024)
        6.3.2 World Hemoglobinopathy Testing Services Market Size by Application (2025-2030)
        6.3.3 World Hemoglobinopathy Testing Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Hemoglobinopathy Testing Services Product and Services
        7.1.4 Novartis Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Hemoglobinopathy Testing Services Product and Services
        7.2.4 AstraZeneca Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Bluebird Bio
        7.3.1 Bluebird Bio Details
        7.3.2 Bluebird Bio Major Business
        7.3.3 Bluebird Bio Hemoglobinopathy Testing Services Product and Services
        7.3.4 Bluebird Bio Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bluebird Bio Recent Developments/Updates
        7.3.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Details
        7.4.2 Bristol-Myers Squibb Major Business
        7.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Product and Services
        7.4.4 Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Bristol-Myers Squibb Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.5 Emmaus Medical
        7.5.1 Emmaus Medical Details
        7.5.2 Emmaus Medical Major Business
        7.5.3 Emmaus Medical Hemoglobinopathy Testing Services Product and Services
        7.5.4 Emmaus Medical Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Emmaus Medical Recent Developments/Updates
        7.5.6 Emmaus Medical Competitive Strengths & Weaknesses
    7.6 Acceleron Pharma
        7.6.1 Acceleron Pharma Details
        7.6.2 Acceleron Pharma Major Business
        7.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Product and Services
        7.6.4 Acceleron Pharma Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Acceleron Pharma Recent Developments/Updates
        7.6.6 Acceleron Pharma Competitive Strengths & Weaknesses
    7.7 HemaQuest Pharmaceuticals
        7.7.1 HemaQuest Pharmaceuticals Details
        7.7.2 HemaQuest Pharmaceuticals Major Business
        7.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product and Services
        7.7.4 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 HemaQuest Pharmaceuticals Recent Developments/Updates
        7.7.6 HemaQuest Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Eli Lilly and Company
        7.8.1 Eli Lilly and Company Details
        7.8.2 Eli Lilly and Company Major Business
        7.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Product and Services
        7.8.4 Eli Lilly and Company Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Eli Lilly and Company Recent Developments/Updates
        7.8.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.9 Celgene Corporation
        7.9.1 Celgene Corporation Details
        7.9.2 Celgene Corporation Major Business
        7.9.3 Celgene Corporation Hemoglobinopathy Testing Services Product and Services
        7.9.4 Celgene Corporation Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Celgene Corporation Recent Developments/Updates
        7.9.6 Celgene Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hemoglobinopathy Testing Services Industry Chain
    8.2 Hemoglobinopathy Testing Services Upstream Analysis
    8.3 Hemoglobinopathy Testing Services Midstream Analysis
    8.4 Hemoglobinopathy Testing Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Hemoglobinopathy Testing Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Hemoglobinopathy Testing Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Hemoglobinopathy Testing Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Hemoglobinopathy Testing Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Hemoglobinopathy Testing Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Hemoglobinopathy Testing Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Hemoglobinopathy Testing Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Hemoglobinopathy Testing Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Hemoglobinopathy Testing Services Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Hemoglobinopathy Testing Services Players in 2023
 Table 12. World Hemoglobinopathy Testing Services Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Hemoglobinopathy Testing Services Company Evaluation Quadrant
 Table 14. Head Office of Key Hemoglobinopathy Testing Services Players
 Table 15. Hemoglobinopathy Testing Services Market: Company Product Type Footprint
 Table 16. Hemoglobinopathy Testing Services Market: Company Product Application Footprint
 Table 17. Hemoglobinopathy Testing Services Mergers & Acquisitions Activity
 Table 18. United States VS China Hemoglobinopathy Testing Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Hemoglobinopathy Testing Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Hemoglobinopathy Testing Services Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Hemoglobinopathy Testing Services Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Hemoglobinopathy Testing Services Revenue Market Share (2019-2024)
 Table 23. China Based Hemoglobinopathy Testing Services Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Hemoglobinopathy Testing Services Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Hemoglobinopathy Testing Services Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Hemoglobinopathy Testing Services Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Hemoglobinopathy Testing Services Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Hemoglobinopathy Testing Services Revenue Market Share (2019-2024)
 Table 29. World Hemoglobinopathy Testing Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Hemoglobinopathy Testing Services Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Hemoglobinopathy Testing Services Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Hemoglobinopathy Testing Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Hemoglobinopathy Testing Services Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Hemoglobinopathy Testing Services Market Size by Application (2025-2030) & (USD Million)
 Table 35. Novartis Basic Information, Manufacturing Base and Competitors
 Table 36. Novartis Major Business
 Table 37. Novartis Hemoglobinopathy Testing Services Product and Services
 Table 38. Novartis Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Novartis Recent Developments/Updates
 Table 40. Novartis Competitive Strengths & Weaknesses
 Table 41. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 42. AstraZeneca Major Business
 Table 43. AstraZeneca Hemoglobinopathy Testing Services Product and Services
 Table 44. AstraZeneca Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. AstraZeneca Recent Developments/Updates
 Table 46. AstraZeneca Competitive Strengths & Weaknesses
 Table 47. Bluebird Bio Basic Information, Manufacturing Base and Competitors
 Table 48. Bluebird Bio Major Business
 Table 49. Bluebird Bio Hemoglobinopathy Testing Services Product and Services
 Table 50. Bluebird Bio Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Bluebird Bio Recent Developments/Updates
 Table 52. Bluebird Bio Competitive Strengths & Weaknesses
 Table 53. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 54. Bristol-Myers Squibb Major Business
 Table 55. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product and Services
 Table 56. Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Bristol-Myers Squibb Recent Developments/Updates
 Table 58. Bristol-Myers Squibb Competitive Strengths & Weaknesses
 Table 59. Emmaus Medical Basic Information, Manufacturing Base and Competitors
 Table 60. Emmaus Medical Major Business
 Table 61. Emmaus Medical Hemoglobinopathy Testing Services Product and Services
 Table 62. Emmaus Medical Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Emmaus Medical Recent Developments/Updates
 Table 64. Emmaus Medical Competitive Strengths & Weaknesses
 Table 65. Acceleron Pharma Basic Information, Manufacturing Base and Competitors
 Table 66. Acceleron Pharma Major Business
 Table 67. Acceleron Pharma Hemoglobinopathy Testing Services Product and Services
 Table 68. Acceleron Pharma Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Acceleron Pharma Recent Developments/Updates
 Table 70. Acceleron Pharma Competitive Strengths & Weaknesses
 Table 71. HemaQuest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 72. HemaQuest Pharmaceuticals Major Business
 Table 73. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product and Services
 Table 74. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. HemaQuest Pharmaceuticals Recent Developments/Updates
 Table 76. HemaQuest Pharmaceuticals Competitive Strengths & Weaknesses
 Table 77. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
 Table 78. Eli Lilly and Company Major Business
 Table 79. Eli Lilly and Company Hemoglobinopathy Testing Services Product and Services
 Table 80. Eli Lilly and Company Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Eli Lilly and Company Recent Developments/Updates
 Table 82. Eli Lilly and Company Competitive Strengths & Weaknesses
 Table 83. Celgene Corporation Basic Information, Manufacturing Base and Competitors
 Table 84. Celgene Corporation Major Business
 Table 85. Celgene Corporation Hemoglobinopathy Testing Services Product and Services
 Table 86. Celgene Corporation Hemoglobinopathy Testing Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Celgene Corporation Recent Developments/Updates
 Table 88. Celgene Corporation Competitive Strengths & Weaknesses
 Table 89. Global Key Players of Hemoglobinopathy Testing Services Upstream (Raw Materials)
 Table 90. Global Hemoglobinopathy Testing Services Typical Customers


List of Figures
 Figure 1. Hemoglobinopathy Testing Services Picture
 Figure 2. World Hemoglobinopathy Testing Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Hemoglobinopathy Testing Services Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Hemoglobinopathy Testing Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Hemoglobinopathy Testing Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Hemoglobinopathy Testing Services Revenue (2019-2030) & (USD Million)
 Figure 13. Hemoglobinopathy Testing Services Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Hemoglobinopathy Testing Services Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Hemoglobinopathy Testing Services Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Hemoglobinopathy Testing Services by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Hemoglobinopathy Testing Services Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Hemoglobinopathy Testing Services Markets in 2023
 Figure 27. United States VS China: Hemoglobinopathy Testing Services Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Hemoglobinopathy Testing Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Hemoglobinopathy Testing Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Hemoglobinopathy Testing Services Market Size Market Share by Type in 2023
 Figure 31. Hydroxyurea
 Figure 32. Glutamine
 Figure 33. Zynteglo
 Figure 34. Luspatercept
 Figure 35. Others
 Figure 36. World Hemoglobinopathy Testing Services Market Size Market Share by Type (2019-2030)
 Figure 37. World Hemoglobinopathy Testing Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 38. World Hemoglobinopathy Testing Services Market Size Market Share by Application in 2023
 Figure 39. Sickle Cell Diseases
 Figure 40. Thalassemia
 Figure 41. Other
 Figure 42. World Hemoglobinopathy Testing Services Market Size Market Share by Application (2019-2030)
 Figure 43. Hemoglobinopathy Testing Services Industrial Chain
 Figure 44. Methodology
 Figure 45. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation

Related Reports

Global Hemoglobinopathy Testing Services Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Hemoglobinopathy Testing Services Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 09 Feb 2021

date Pharma & Healthcare

The Hemoglobinopathy Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Hemoglobinopathy Testing Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Hemoglobinopathy Testing Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

Global Hemoglobinopathy Testing Services Supply, Demand and Key Producers, 2023-2029

Global Hemoglobinopathy Testing Services Supply, Demand and Key Producers, 2023-2029

date 14 Aug 2023

date Pharma & Healthcare

The global Hemoglobinopathy Testing Services market size is expected to reach $ 1547.6 million by 2029, rising at a market growth of 9.0% CAGR during the forecast period (2023-2029).

Global Hemoglobinopathy Testing Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Hemoglobinopathy Testing Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 14 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hemoglobinopathy Testing Services market size was valued at USD 848.9 million in 2022 and is forecast to a readjusted size of USD 1547.6 million by 2029 with a CAGR of 9.0% during review period.

Global Hemoglobinopathy Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Hemoglobinopathy Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Apr 2024

date Pharma & Healthcare

Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.

Product Tags

hemoglobinopathy testing services

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>